Exhaled nitric oxide from lung periphery is increased in COPD
- 1 July 2005
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 26 (1), 52-59
- https://doi.org/10.1183/09031936.04.00125304
Abstract
Single constant flow exhaled nitric oxide (eNO) cannot distinguish between the sources of NO. The present study measured eNO at multiple expired flows (MEFeNO) to partition NO into alveolar (Calv,NO) and bronchial (Jaw,NO) fractions to investigate peripheral lung contribution to eNO in chronic obstructive lung disease (COPD). MEFeNO were made in 81 subjects including 18 nonsmokers, 16 smokers and 47 COPD patients of different severity by the classification of the Global Initiative for Chronic Obstructive Lung Disease (GOLD): 0 (n = 14), 1 (n = 7), 2 (n = 11), 3 (n = 8) and 4 (n = 7). COPD severity was correlated with an increased Calv,NO regardless of the patient's smoking habit or current treatment. The levels of Calv,NO (in ppb) were 1.4±0.09 in nonsmokers, 2.1±0.1 in smokers categorised as GOLD stage 0 (smokers-GOLD0), 3.3±0.18 in GOLD1–2 and 3.4±0.1 in GOLD3–4. Jaw,NO levels (pL·s−1) were higher in nonsmokers than smokers-GOLD0 (716.2±33.3 versus 464.7±41.8), GOLD3–4 (609.4±71). Diffusion of NO in the airways (Daw,NO pL·ppb−1s−1) was higher (p3–4 than in nonsmokers (15±1.2 versus 11±0.5) and smokers-GOLD0 (11.6±0.5). MEFeNO measurements were reproducible, free from day-to-day and diurnal variation and were not affected by bronchodilators. In conclusion, chronic obstructive pulmonary disease is associated with elevated alveolar nitric oxide. Measurements of nitric oxide at multiple expired flows may be useful in monitoring inflammation and progression of chronic obstructive pulmonary disease, and the response to anti-inflammatory treatment.Keywords
This publication has 20 references indexed in Scilit:
- The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- Modeling pulmonary nitric oxide exchangeJournal of Applied Physiology, 2004
- Airway diffusing capacity of nitric oxide and steroid therapy in asthmaJournal of Applied Physiology, 2004
- Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Secondhand Tobacco Smoke Impairs Rabbit Pulmonary Artery Endothelium-Dependent RelaxationSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2001
- Exhaled Markers of Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Exhaled Nitric Oxide in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide.American Journal of Respiratory and Critical Care Medicine, 1997
- Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract.American Journal of Respiratory and Critical Care Medicine, 1996
- Increased nitric oxide in exhaled air of asthmatic patientsThe Lancet, 1994